HIV: 'I was told I had between three and nine months to live'
'Forgotten epidemic'
HIV is a virus that damages the cells in your immune system and weakens your ability to fight everyday infections and disease.Aids (acquired immune deficiency syndrome) is when a number of potentially life-threatening infections and illnesses happen when the immune system has been severely damaged by the HIV virus.While Aids cannot be transmitted from one person to another, the HIV virus can."It really wasn't until 2015, when they first announced 'U = U', 'Undetectable = Untransmittable', that I was no longer this kind of leper - that I had this poisoned blood, that I could infect anybody," Jonathan said.The term means that if someone has an undetectable viral load, they cannot sexually transmit HIV to others.The Terrence Higgins Trust charity reports that by 1999, 33m people were living with HIV worldwide while the World Health Report listed Aids as the fourth biggest killer worldwide, 20 years after the epidemic began.According to the National Aids Trust, 2023 was the highest year for people receiving HIV care with 107,949 treated - an increase of 27% across the last 10 years.Jonathan said: "HIV is this forgotten epidemic. It is never talked about and it's so important it is. "A lot of that is to do with stigma."He added: "I was on effective medication, because we have an amazing NHS. I am so fortunate that I have had access to the medication."The most important thing to do is know your status, be brave, get tested."The developments that are happening are extraordinary - even though there is no cure," he continued."I'm living proof."
Jonathan attended the launch on Wednesday of the report Getting to zero by 2030: HIV in London at the site of the future HIV/Aids Memorial which is planned to be placed in Fitzrovia.In 2018, the London mayor, London Councils, Public Health England and NHS England signed up to the Fast-Track Cities Declaration to reach zero new HIV infections, zero HIV-related stigma and zero HIV-related deaths by 2030.The report, by the London Assembly Health Committee, found that despite progress in attitudes towards HIV, HIV-related stigma remained prevalent in London and the UK.London has historically had, and continues to have, higher rates of HIV than the rest of the country. However, the London Assembly said the city was leading the way globally to end new HIV cases and was seen as a leading international example through its HIV prevention and treatment programmes.
The Assembly added that "concerted action" would be required to increase testing, improve access to Pre-Exposure Prophylaxis (PrEP), ensure that everyone with HIV could access the care they needed and that services must reach people and communities who were currently missing out on them. Recommendations in the report included:Giving greater prominence to the issue of HIV, with a focus on what key actions were needed to help London reach its 2030 goalThe mayor should promote the HIV Confident charter in London and advocate for more organisations to sign up to it in 2025, including the councils, healthcare settings and businessesThe mayor should help ensure that construction of the HIV/Aids memorial in London was completed by the end of 2027 and use it as an opportunity to work with others to promote anti-stigmatising initiatives and public health messaging in relation HIV
Increase in cases
Chair of the London Assembly Health Committee, Krupesh Hirani, said London was "a long way off" reaching its 2030 target."After many years in which there was a year-on-year decline in new HIV cases, there has been an increase in cases in London and England since 2020. We would like to see the mayor take further action," he said.A spokesperson for the mayor said Sadiq Khan would respond to the Assembly's report in due course.They added: "The current government has committed to commissioning a new HIV action plan and the mayor looks forward to working closely with ministers to help end HIV cases by 2030, as we build a fairer and healthier London for everyone."
In December 2023, the mayor announced £130,000 of funding from the Commission for Diversity in the Public Realm towards the construction of a permanent HIV and Aids memorial in London. Aids Memory UK, which is behind the project, said the memorial would be unveiled at the end of 2027 and the artwork would take the form of a felled tree.Ambassador of Aids Memorial UK, Mzz Kimberley, also known as Kim Tatum, said: "The memorial is going to be a place where people can go and reflect, educate themselves, feel peace, talk to people."This memorial will mean that everyone who lost their life had meaning. "It's a dedication to all the people around the world who've lost their life, or the injustices that society has brought to them."The memorial means a lot to Jonathan, saying it would help "create a community - I am so proud to be part of this HIV community."I've lost lots of friends - some very, very early but some more recently, and it still hurts."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
4 hours ago
- BBC News
London HIV charity Positively UK could close over funding crisis
A London-wide HIV charity has said it could be forced to close if the funding crisis it is facing UK, which has supported people with HIV for almost 40 years, has already closed its pan-London gay men's peer support group after being unable to secure funding for its Petretti, CEO said: "The support we give is very emotional. However, most of the time we have very short-term funding. From one year to another, we never know if we're going to be around."The government said it was "fully committed" to ending new HIV transmissions in England by 2030 and that its upcoming HIV Action Plan would focus on prevention and testing, as well as living well with HIV. According to the National Aids Trust, 2023 was the highest year for people receiving HIV care, with 107,949 treated - an increase of 27% across the last 10 Petretti said: "HIV is not over. We have treatment for HIV, but we don't have a treatment for stigma yet.""Positively UK has existed since the 1980s," she added. "We're going to be 40 next year and I am worried that our services may not be there for people in the future because of the lack of funding."We finished the year in the deficit and one of the most important services for us, the gay men's project, had to stop. In the past two years we applied to nine different funds and we couldn't secure any funding for the project." Phil Dehany started attending the support group four years after he was diagnosed with HIV in 2016."I live by myself here in London and it can be lonely," he said. "Those opportunities to meet up with people once a month were a lifeline."I would go as often as I could, and it's one of those things that you don't miss until it's gone, and I wish now that I'd gone a lot more often.""It was really sad when the project came to an end - straight away you've just lost that connection to that community."Mr Dehany said he now uses a range of other voluntary organisations, but fears that if funding struggles continue, those who need support, including elderly people living with HIV, will suffer. 'Nothing to replace that service' The voluntary and community sectors that offer support services for people living with HIV have faced big cuts in the last decade, the National Aids Trust said.A report by the charity found 71% of London's HIV voluntary, community, and social enterprise organisations had to either reduce staff numbers, close services, merge with other organisations or use cash reserves to cover operating costs in the last three 40% were concerned about their ability to deliver services over the next three Currie, CEO of the National Aids Trust, said: "There's a funding crisis going on within the sector across the UK."Statutory services have been massively reduced. It has really impacted on service provision. Services are either being cut completely or they are being reduced."Of Positively UK, he said: "There's just nothing to replace that service." The government recently pledged to end all new HIV diagnoses by Petretti said: "The government wants the UK to reach zero transmissions by 2030, but if people are not supported to stay well, we will not reach this goal."In June, the Local Government Association warned that sexual health services in England were grappling with "unprecedented pressure" and urged the government to carve out a 10-year strategy and invest more to deliver "expert, timely care".A spokesperson for the Department of Health and Social Care said its 10-year health plan focused on how local government could improve services for sexual health by making better use of funding and working more closely with the added: "We are fully committed to ending new HIV transmissions in England by 2030 and our upcoming HIV Action Plan will focus not just on prevention and testing, but also on helping people live well with HIV."They said more than £6m had been invested in the National HIV Prevention Programme and £27m of funding was announced in December. Additional reporting by Josef Steen, Local Democracy Reporting Service.
Daily Mail
4 days ago
- Daily Mail
GSK boss 'highly confident' sales will top £40bn by 2031 as firm cashes in on cancer and HIV drugs
GSK's boss said she was 'highly confident' sales will top £40billion by 2031 as the group cashes in on speciality medicines for cancer, HIV and other conditions. With the pharmaceuticals giant's HIV business as well as respiratory and oncology divisions recording double-digit revenue growth, Emma Walmsley said sales and profits are on course to be 'towards the top end' of expectations. Revenues rose 5 per cent to £15.5billion in the first half of the year and profits were up 41 per cent to £4.2billion. Shrugging off the impact of US tariffs, Walmsley added: 'With the breadth of our current business and the growth opportunities we have in our pipeline, we are highly confident in our outlook for sales of more than £40billion by 2031.' The updated guidance had taken into account the tariffs implemented and expected tariffs on European goods.
The Independent
4 days ago
- The Independent
A single injection for newborns could protect them against HIV for years, study suggests
A single injection at birth could shield children from HIV for years, a study has suggested. The study is one of the first to show that the first weeks of life offer a critical window where the immune system is naturally more tolerant, meaning it is the optimal time to deliver gene therapies that would otherwise be rejected at older ages. Researchers hope the gene therapy jab could be used in the future to fight against paediatric infections in high-risk areas. 'Nearly 300 children are infected with HIV each day,' said first author Amir Ardeshir, associate professor of microbiology and immunology at the Tulane National Primate Research Center in the US. 'This approach could help protect newborns in high-risk areas during the most vulnerable period of their lives.' The study, published in the journal Nature, created a gene therapy that programs cells to produce HIV-fighting antibodies. An animal study that tested the injection on non-human primates found it protected them from infection for at least three years without the need for a booster shot. But this was only if the injection was administered in the first month of life. In comparison, those that received the gene therapy between eight and 12 weeks after birth did not tolerate the treatment, study authors explain. 'This is a one-and-done treatment that fits the critical time when these mothers with HIV in resource-limited areas are most likely to see a doctor,' Dr Ardeshir said. 'As long as the treatment is delivered close to birth, the baby's immune system will accept it and believe it's part of itself.' Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health Organization (WHO). But if they do not receive medication, the rate of transmission of HIV from the mother to her child either during pregnancy, labour, delivery or breastfeeding ranges between 15 per cent and 45 per cent, according to WHO data. Although antiviral treatments can suppress the virus and limit transmission, adherence to treatment and doctor visits decline after childbirth, particularly in areas with limited access to healthcare, the study authors noted. This gene therapy uses a harmless virus that can deliver genetic code to cells, but is different to a vaccine. This virus was injected into muscle cells and delivered instructions to produce antibodies that are capable of neutralising multiple strains of HIV. Researchers explained that previous studies have found repeated infusions of the injection are needed for it to work. But by injecting it into muscle cells, researchers say they become 'micro-factories that just keep producing these antibodies'. Newborns showed greater tolerance to the jab, which prevented infection during breastfeeding. However, older infants and juveniles were more likely to have produced anti-drug antibodies that shut down the treatment. In addition, exposing a foetus to the antibodies from the gene therapy before birth helps older infants accept the therapy. However, because it has only been tested on animals, researchers still do not know if it will work on human children. If successful, this treatment could dramatically reduce mother-to-child HIV transmission rates in high-risk regions such as sub-Saharan Africa, where 90 per cent of paediatric HIV cases can be found. 'Nothing like this was possible to achieve even 10 years ago,' Dr Ardeshir said. 'This was a huge result, and now we have all the ingredients to take on HIV.'
